pharma

After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/

There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...

Walgreens to buy pharmacy files from 185 Fred's stores for $165 million. Walgreens will be strengthening their presence in Southeastern US through this deal. https://news.alphastreet.com/walgreens-acquires-freds-inc-pharmacy-165-million/

Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will be a real threat to Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...

Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...

In the past two weeks, Celgene has reported positive results from 3 clinical trials. This includes two studies with its partner Acceleron. https://news.alphastreet.com/celgene-gets-a-booster-shot-from-recent-positive-clinical-trial-results/

Trump has been speaking and tweeting about the higher drug prices for nearly two years and still he has not taken any steps in reducing the prices of the drugs. Pfizer and other pharma companies are taking advantage and increasing their drug prices often. When will this stop...

Shares of biotech company Biogen (BIIB) rallied on Thursday during the after-hours trading after the company said it achieved positive results from final analysis of its Phase II trial of an Alzheimer’s drug. The advanced drug candidate, BAN2401, was developed in partnership with a Tokyo-based...

Anybody else hearing chatter within any of the larger Pharma shopping around. Hearing very promising results

http://www.cafepharma.com/boards/threads/the-new-reality-of-whats-left-of-merck-employees.609591/ At least it's not so bad in IT. It's not like our clients have zero confidence in us or outright despise us since the cybersecurity incident and our leadership still have no clue. Merck -...

Abbott reported worldwide sales of $7.4 billion for the first quarter of 2018, an increase of 16.7% versus the prior-year period, helped by new product launches. Net earnings on a GAAP basis came in at $418 million or $0.23 per share, down slightly from the prior-year quarter. On an adjusted...

Sanofi plans to offload its European generics business Zentiva that it acquired in 2009. Several bidders had earlier dropped out of an auction, but latest news suggests that the company is nearing an agreement and may soon finalize the sale. According to Reuters, private equity firm Advent...

Johnson & Johnson may not be having a great 2018 so far with the stock ticking down about 8% since the year started. But is it time to get rid of the world’s largest pharma company’s shares? Let’s see.

There is a lot to look forward to as Mylan reports earnings aftermarket today. The stock has been up 9.65% since it reported last quarter results. Market pundits expect earnings to be lower this quarter, complemented by a sales decline of 0.80%...

Privately-held Albertsons Companies is planning to buy the portion of Rite Aid that is not being sold to Walgreens Boots Alliance. The combined value of Albertsons and Rite Aid, including debt, is around $24 billion. The proposed cash-and-stock deal will give Albertsons shareholders ownership...

If you ask Sansa Stark from HBO’s Game of Thrones, she’ll tell you the best way to go is to team up with someone strong or risk getting killed. And that’s what happens to most acquisitions in the market nowadays. Over the past three years or so, we have seen a plethora of deal announcements...

Eli Lilly reports an increase in pharma sales and decline in Animal Health. Lifts 2018 earnings outlook. When answering an analyst question, Enrique Conterno said, "We continue to see pressure on pricing across all of our diabetes products".

As an senior academic +25 years service, I have seen a dive to’ the bottom when’ we are invited to provide consulting services and’ ad board service to the’ pharmaceutical sectors’. They are paying less good rates, flights on cheapest enc class seats, on bugdet airlines for senior PhD or more...

From leaders like Len/George to the lowest admin scum... https://www.streetinsider.com/Corporate+News/Merus+N.V.+%28MRUS%29+Says+U.S.+Court+of+Appeals+Denies+Regenerons+%28REGN%29+Petition+to+Rehear+the+Panels+Decision+on+018+Patent/13632058.html This article says it all. Do some more research...

CVS health profit was hit due to temporary store closure that occurred during Hurricane Harvey. Few of its stores are still recovering from the affect of the hurricane. Atena is said to have a medical membership of over 20 Million. If the two companies pair up, cvs could open the pharmacy...